Studies using telomerase peptides as a vaccination approach showed that it may be used as an attractive target for novel immunotherapies against cancer, by CTLs that can recognize peptides derived from TERT and eliminate TERT-positive tumor cells in murine and humans [22]. The gene discussed is TERT; the disease is neoplasm.